Chiara Mozzini Selected Research

Chiara Mozzini Research Topics

Disease

5	Inflammation (Inflammations) 02/2021 - 01/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021 - 03/2014
2	Myocardial Infarction 10/2022 - 02/2017
2	Atherosclerosis 09/2022 - 01/2008
1	Heart Failure 09/2023
1	Left Ventricular Outflow Obstruction 09/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2023
1	Infections 10/2022
1	Progeria (Hutchinson Gilford Syndrome) 09/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2021
1	Virus Diseases (Viral Diseases) 02/2021
1	COVID-19 02/2021
1	Peripheral Arterial Disease 09/2018
1	Ischemia 09/2018
1	Stable Angina 01/2018
1	Unstable Angina 01/2018
1	Alcoholism (Alcohol Abuse) 10/2017
1	Brain Edema (Cerebral Edema) 10/2017
1	Pulmonary Edema 10/2017
1	Rhabdomyolysis 10/2017
1	Renal Insufficiency (Renal Failure) 10/2017
1	Seizures (Absence Seizure) 10/2017
1	Disseminated Intravascular Coagulation 10/2017
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Liver Failure 10/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Emphysema 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Diabetes Mellitus 11/2015
1	Liver Diseases (Liver Disease) 11/2015
1	Obesity 11/2015
1	Hypoxia (Hypoxemia) 11/2015
1	Thrombosis (Thrombus) 08/2014
1	Vascular Remodeling 01/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008

Drug/Important Bio-Agent (IBA)

4	NF-kappa B (NF-kB)IBA 09/2022 - 12/2009
4	AntioxidantsIBA 02/2021 - 01/2008
3	Phenobarbital (Luminal)FDA Link 10/2022 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021 - 09/2018
2	oxidized low density lipoproteinIBA 01/2018 - 01/2008
2	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 01/2016 - 03/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2023
1	omecamtiv mecarbilIBA 09/2023
1	Neprilysin (Neutral Endopeptidase)IBA 09/2023
1	SodiumIBA 09/2023
1	Cardiac MyosinsIBA 09/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2023
1	Mineralocorticoid Receptor AntagonistsIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 09/2023
1	SymportersIBA 09/2023
1	MYK-461IBA 09/2023
1	ChromatinIBA 10/2022
1	Lamin Type A (Lamin A)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Uric Acid (Urate)IBA 05/2021
1	InflammasomesIBA 02/2021
1	NLR ProteinsIBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	InterleukinsIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	SolutionsIBA 10/2017
1	Dacarbazine (DIC)FDA LinkGeneric 10/2017
1	Malondialdehyde (Propanedial)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	ElementsIBA 03/2014
1	1- palmitoyl- 2- arachidonyl- 3- phosphorylcholineIBA 03/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2008
1	Atenolol (Tenormin)FDA LinkGeneric 01/2008
1	Nebivolol FDA Link 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2008
1	P-SelectinIBA 01/2008
1	E-SelectinIBA 01/2008
1	Endothelin-1 (Endothelin 1)IBA 01/2008
1	Thromboplastin (Tissue Factor)IBA 01/2008
1	HomocysteineIBA 01/2008
1	Fibrinogen (Factor I)FDA Link 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2023
1	Secondary Prevention 05/2021